Rate My Professor Roslyn Kemp

Professor Kemp's research specializes in immunology, focusing on T cells as mediators of anti-tumour immunity and inflammation, particularly the roles of T cell and myeloid cell subsets in colorectal cancer, inflammatory bowel disease, and mucosal immune responses. Her projects explore patient outcomes, gut-specific immunity using organoids, vaccination for T cell memory, and high-dimensional immune analysis. Key publications include "High dimensional mass cytometric analysis reveals an increase in effector regulatory T cells as a distinguishing feature of colorectal tumors" (Journal of Immunology, 2019), "The immune checkpoint CD96 defines a distinct lymphocyte phenotype & is highly expressed on tumor-infiltrating T cells" (Immunology & Cell Biology, 2018), and "Regulatory T cell heterogeneity and the cancer immune response" (Clinical & Translational Immunology, 2017). She has received the Derrick Rowley Medal for Service to the Australasian Society of Immunology (2025), Roche Translational Cancer Research Fellowship (2016), Miriam Dell Award (2015), National Tertiary Teaching Excellence Award (2015), and University of Otago Supervisor of the Year (2013 and 2020). Kemp has held positions as Secretary-General of the International Union of Immunological Societies (2016-2019), President of the New Zealand Society for Oncology (2017-2019), and co-chair of IUIS committees on publications, education, and gender equity. She is a member of the Ako Aotearoa Academy of Tertiary Teaching Excellence.